Introduction
The effectiveness of current cancer immunotherapies is critically dependent on the presence of activated effector T cells in the tumor microenvironment (TME), and preexisting T cell infiltration in solid tumors holds a prognostic value because it is associated with clinical response (1) . Despite the operation of immune surveillance mechanisms, tumors form endowed immunosuppressive networks that impede the elicitation of potent antitumor immune responses and impair the success of immunotherapy (2) 
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+ CD15 + cells (3) (4) (5) . Multiple mechanisms have been attributed to MDSC-mediated inhibition of antitumor immune responses, ranging from secretion of immunosuppressive mediators to direct cell-to-cell contact (6-7). To date, major therapeutic efforts in cancer aim to switch the differentiation and function of MDSCs toward an immunogenic phenotype.
Autophagy is a fundamental lysosomal catabolic pathway involving degradation of unwanted proteins and organelles to maintain nutrient and cell homeostasis (8) . The autophagy pathway is induced under hypoxic conditions, and hypoxia is a cardinal feature of most tumors that possesses a major role in tumor progression, metastasis, and response to therapy (9) . Although most studies have focused on the role of autophagy in tumor cells (10) , how this pathway affects the immune components of the TME and specifically MDSCs remains unknown. Several lines of evidence, however, have indirectly shown autophagy to be a major regulator of MDSC function. To this end, hypoxia-inducible factor 1α (HIF-1α), which regulates autophagy, has been demonstrated to promote MDSC differentiation toward tumor-associated macrophages (11) (12) (13) . Moreover, high-mobility group box protein 1 has been shown to promote MDSC survival through induction of autophagy and pharmacologic inhibition of autophagy-induced MDSC cell death (14) . In a similar fashion, endoplasmic reticulum (ER) stress that activates autophagy as a compensatory mechanism for cell survival has been linked to TRAIL-R-mediated MDSC apoptosis (15) (16) (17) . Finally, ROS are central in inducing autophagy and have been demonstrated to regulate the stress sensor CHOP in MDSCs that facilitates MDSC accumulation and function (18, 19) , suggesting that autophagy might be implicated in MDSC suppression. Although all aforementioned reports indicate a possible link of autophagy to the function of tumor-associated MDSCs, a direct role of this pathway as well as the precise autophagy-related molecular events in MDSC-mediated suppression of antitumor immunity remain elusive.
Myeloid-derived suppressor cells (MDSCs) densely accumulate into tumors and potently suppress antitumor immune responses, promoting tumor development. Targeting MDSCs in tumor immunotherapy has been hampered by lack of understanding of the molecular pathways that govern MDSC differentiation and function. Herein, we identify autophagy as a crucial pathway for MDSC-mediated suppression of antitumor immunity. Specifically, MDSCs in patients with melanoma and mouse melanoma exhibited increased levels of functional autophagy. Ablation of autophagy in myeloid cells markedly delayed tumor growth and endowed antitumor immune responses. Notably, tumor-infiltrating autophagy-deficient monocytic MDSCs (M-MDSCs) demonstrated impaired suppressive activity in vitro and in vivo, whereas transcriptome analysis revealed substantial differences in genes related to lysosomal function. Accordingly, autophagy-deficient M-MDSCs exhibited impaired lysosomal degradation, thereby enhancing surface expression of MHC class II molecules, resulting in efficient activation of tumor-specific CD4 + T cells. Finally, targeting of the membrane-associated RING-CH1 (MARCH1) E3 ubiquitin ligase that mediates the lysosomal degradation of MHC II in M-MDSCs attenuated their suppressive function, and resulted in markedly decreased tumor volume followed by development of a robust antitumor immunity. Collectively, these findings depict autophagy as a molecular target of MDSC-mediated suppression of antitumor immunity.
Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells Figure 2A) . In addition,
Atg5
ΔLysM mice did not show any alterations in the frequencies of CD4 + T cells, CD8 + T cells, and Foxp3 + Tregs either in the thymus or in the lymph nodes (LNs) (Supplemental Figure 2 , C and D). Interestingly, B16-F10 melanoma growth was significantly attenuated in Atg5
ΔLysM mice as compared with control Atg5 fl/fl mice ( Figure 3A ). This was not restricted to melanoma cells, since significant inhibition of Lewis lung carcinoma (LLC) cell growth was observed in Atg5
ΔLysM mice compared with Atg5 fl/fl littermates ( Figure 3B ). Analysis of tumor-draining LNs (tdLNs) revealed no differences in the frequencies of CD4 + and CD8 + T cells, whereas Foxp3 + Tregs were significantly reduced in melanoma-bearing Atg5
ΔLysM mice ( Figure 3C ). However, analysis of tumor-infiltrating cells demonstrated significantly increased frequencies of CD45 + cells and CD4 + lymphocytes in Atg5 ΔLysM mice, whereas the levels of tumor-infiltrating Foxp3 + Tregs were markedly decreased compared with control animals ( Figure 3D ). In addition, the expression of Foxp3 CTLA4 and CD73 was not altered on Tregs, whereas expression of GITR was significantly decreased (Supplemental Figure 3 ). Immunohistological analysis of tumors confirmed the increased frequencies of CD4 + cells in Atg5 ΔLysM mice ( Figure 3E ). In addition, the frequencies of NK1.1 + cells significantly decreased in the tumors of Atg5
ΔLysM mice ( Figure 3F ). Importantly, CD8 + and NK1.1 + infiltrating cells in Atg5 ΔLysM mice expressed significantly increased levels of IFN-γ compared with control animals ( Figure  3 , F and G). Overall, these findings demonstrate that absence of autophagy in the myeloid compartment elicits a robust antitumor immune response that attenuates tumor growth.
Tumor-derived autophagy-deficient M-MDSCs highly accumulate into tumors and exhibit diminished suppressive activity. We next asked how the MDSC compartment was affected during tumor development in Atg5
ΔLysM mice. We observed increased frequencies of CD11b +
Gr1
+ MDSCs in the spleens of tumor-inoculated Atg5
ΔLysM mice compared with control animals, whereas frequencies of CD11c + DCs were not altered ( Figure 4A ). This was reflected by an increased accumulation of G-MDSCs and decreased levels of M-MDSCs ( Figure 4B) . Surprisingly, we found markedly increased frequencies of total MDSCs in tumors of Atg5
ΔLysM mice ( Figure 4C ), with a prominent increase in M-MDSCs, whereas frequencies of G-MDSCs were not different ( Figure 4D ). Immunohistochemistry of tumor sections with CD206, a marker expressed by tumorassociated monocytes (26) , confirmed the increased infiltration of myeloid cells in Atg5
ΔLysM tumors ( Figure 4E ). In addition, we
In this study, we delineate an important role of autophagy in M-MDSC-mediated suppression of antitumor immune responses. We demonstrate that autophagy-deficient M-MDSCs are reprogrammed, since they lose their suppressive activity and promote antitumor immune responses. Absence of autophagy deregulates the lysosomal function of M-MDSCs that entails insufficient lysosomal degradation and subsequently elevated surface expression of MHC class II. Overall, these findings propose that manipulation of the autophagy pathway in MDSCs could be considered an immunotherapeutic protocol in cancer. Figure 1A) , following the updated guidelines for autophagy (20) . Using immunofluorescence microscopy, we determined formation of functional autophagolysosomes based on the expression of LC3 that denotes formation of autophagosomes (20, 21) , the lysosomal-associated membrane protein 1 (LAMP-1), and the adaptor protein SQSTM1/p62 that targets ubiquitinated proteins for lysosomal degradation (22) . Notably, increased formation of autophagosomes was demonstrated in MDSCs from patients with melanoma compared with MDSCs from healthy individuals, and colocalization analysis revealed increased puncta positive for both p62 and LC3, indicating operation of functional autophagy ( Figure 1B ). Next we examined MDSC autophagy levels in a clinically relevant melanoma mouse model that entails subcutaneous injection of B16-F10 melanoma cells into C57/ BL6 mice. Upon melanoma establishment, CD11c -CD11b + Gr1 + MDSCs were significantly enriched in the spleen of tumor-bearing mice, whereas the frequencies of the monocytic and granulocytic MDSC subsets were not altered ( Figure 2A ). Furthermore, assessment of autophagy in sorted MDSCs indicated increased levels of autophagosome formation and decreased levels of p62 compared with naive animals ( Figure 2B ). Importantly, MDSCs from tumors also demonstrated a prominent autophagolysomal function based on LC3 and p62 expression ( Figure 2B ). The kinase mTOR-dependent pathway is the best-characterized regulator of autophagy, and activation of the PI3K/Akt axis is an upstream modulator of mTOR activity (23) . To this end, we observed decreased phosphorylation of AKT (pAKT), mTOR (pmTOR), and the ribosomal protein S6 (pS6) in MDSCs from melanoma-bearing mice compared with naive controls ( Figure  2C ). In addition, phosphorylation of serine/threonine kinase UNC-51-like kinase 1 (ULK-1), which is required for activation of the preinitiation complex in the canonical pathway of autophagy (24, 25) , was significantly increased in MDSCs from spleen and tumors of melanoma mice ( Figure 2D ). Collectively, these findings demonstrate a substantial upregulation and completion of the autophagy pathway in MDSCs from patients with melanoma and melanoma-bearing mice.
Results

Increased autophagy in
Because MDSCs comprise a heterogeneous population of monocytic and granulocytic progenitors (4), we sought to determine how the autophagy pathway is regulated in the respective MDSC subsets. To this end, both subsets exhibited enhanced
jci.org Volume 128 Number 9 September 2018 tumor volume and weight ( Figure 4G ) and increased frequencies of CD4 + T cells in tdLNs compared with control M-MDSCs (Figure 4H) . Collectively, these data demonstrate that tumor-derived autophagy-deficient M-MDSCs exhibit diminished suppressive activity in vitro and in vivo.
Autophagy deficiency enhances the immunogenic properties of tumor-derived M-MDSCs through impaired lysosomal degradation of MHC II molecules. To elucidate the molecular mechanism through which autophagy dictates the suppressive activity of M-MDSCs, we performed whole-genome RNA sequencing of M-MDSCs isolated from tumor-inoculated Atg5
ΔLysM and control animals and we found more than 1,300 genes to be differentially regulated ( Figure 5A ). Clustering and gene ontology analysis pointed to an enrichment of genes encoding molecules that belong to the lysosomal compartment ( Figure 5B ). In support of this, flow cytometric analysis of LysoSensor Green (DND-189), a weak base that accumulates in acidic organelles and which fluorescence is increased upon protonfound that all MDSCs expressed CD115 in the tumor milieu, and that CD40 expression, which has been linked to Treg induction by MDSCs (27) , was significantly upregulated in Atg5
ΔLysM mice (Supplemental Figure 4A ). Of interest, increased apoptosis was observed in tumor-infiltrating autophagy-deficient M-MDSCs (Supplemental Figure 4B ), likely because of their increased turnover.
The augmented frequencies of M-MDSCs in the TME of Atg5
ΔLysM mice along with attenuated tumor growth prompted us to examine the functional properties of autophagy-deficient M-MDSCs. Thus we sorted highly pure M-MDSCs from tumors of Atg5
ΔLysM and control mice and examined their suppressive properties in vitro. To this end, M-MDSCs from Atg5
ΔLysM mice failed to suppress the proliferation as well as activation (based on CD44 expression) of CD4 + T cells, in contrast to M-MDSCs isolated from control animals, which were highly suppressive in vitro ( Figure  4F ). Importantly, coinjection of M-MDSCs from tumor-inoculated Atg5
ΔLysM mice with B16-F10 cells resulted in significantly reduced Figure 5C ). Furthermore, we assessed the expression of Rab7 GTPase, which is known to regulate intracellular membrane trafficking of endo- ) (n = 5 mice per group, ***P < 0.0001) and subsets from spleens of naive or B16-F10-inoculated mice (n = 4). (B) Representative immunofluorescence confocal images for LC3 (red), LAMP-1 (green), p62 (silver white), and DAPI (blue), and LC3 puncta/cell and p62 puncta/ cell in sorted MDSCs from spleens and tumors of naive and B16-F10-inoculated mice (n = 4 mice per group) (LC3: ***P < 0.0001; p62: *P = 0.0459, **P = 0.0003, ***P < 0.0001). Scale bars: 10 μm. ΔLysM mice, suggesting an incomplete degradation of MHC II. Finally, in vitro blocking of lysosomal function substantially increased MHC class II surface expression without affecting IA b or Ciita gene expression. All the above pointed toward an autophagy-dependent aberrant lysosomal degradation of MHC II molecules in tumor-associated M-MDSCs. In line with our results, earlier studies showed that DCs with limited lysosomal proteolysis are more potent APCs than macrophages with high proteolytic capacity (43) . To date, lysosomal degradation of MHC II molecules is considered to play an instrumental role in determining the levels of surface MHC II expression (30, 44, 45) . Specifically, MHC II surface expression is regulated by the E3 ubiquitin ligase membrane-associated RING-CH1 (MARCH1), which mediates intracellular localization and lysosomal degradation of pMHC-II in DCs (46) and B cells (47).
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jci.org Volume 128 Number 9 September 2018 Our data demonstrate that the mTOR pathway is downregulated in MDSCs from tumor-inoculated mice, which is in agreement with increased autophagy levels. Although mTOR signaling regulates various physiological as well as pathological processes and has also been shown to affect autophagosome-lysosome fusion (51), its role in MDSC function just emerged. Specifically, it development of an antitumor immunity remains a caveat of such approaches. Targeted delivery of autophagy inhibitors (e.g., via nanoparticles) to MDSCs should be tested for the ability to generate immunity against tumors, and could pave the way for the design of novel therapeutic protocols in cancer.
Methods
Mice. C57BL/6 mice were purchased from the Jackson Laboratory, and Atg5 ΔLysM mice were generated by crossing Atg5 fl/fl mice (62) has been demonstrated that lysosomal acid lipase (lal) in MDSCs regulated their metabolic reprogramming and expansion mostly in granulocytic lineage and also that lal -MDSCs exhibited increased activation of the mTOR signaling pathway (52) . In a follow-up study, Rab7 GTPase was identified to regulate the mTOR in lal -MDSCs and inhibition of Rab7 function substantially reduced MDSC differentiation as well as trans-endothelial migration (53) . Our data show that impaired lysosomal function in autophagydeficient M-MDSCs is associated with decreased levels of Rab7, but had no effect on total LAMP-1 expression. Since MDSCs constitute a heterogenous population of monocytic and granulocytic cells that potently suppress antitumor immune responses, the delineation of signals that regulate the metabolic activities and are linked to lysosomal genesis and function in each subset are of great importance and warrant further investigation.
Given that MDSCs are the progenitors of granulocytes, macrophages, and DCs, delineation of the mechanisms involved in the MDSC differentiation are crucial for the development of therapeutic regimens that will benefit patients with cancer. Several methods have been developed to achieve this goal (4, 54, 55); however, the clinical implementation of these approaches and their specificity have not been examined. Our findings propose targeting of autophagy as a novel pathway to alter M-MDSC suppressive activity. Indeed, whole-genome transcriptomic analysis of tumor-derived M-MDSCs provided evidence for a major impact of autophagy on their phenotype, which was confirmed with in vitro and in vivo functional assays. The autophagy pathway was found to be markedly upregulated in MDSCs from melanoma-bearing mice as well as patients with melanoma. Several factors could contribute to increased MDSC autophagy in tumors. Reduced oxygen supply is a cardinal feature of the TME and it has been linked to induction of autophagy (56) , a process that is regulated through HIF-1α (57) . Expression of HIF-1α has been closely linked to MDSC differentiation, since HIF-1α-deficient MDSCs fail to suppress and instead differentiate toward DCs and macrophages (12, 58) . However, whether HIF-1α deficiency in tumor-exposed MDSCs affects operation of autophagy was not addressed. Alternatively, under hypoxic conditions, M-MDSCs upregulated the expression of CD45 tyrosine phosphatase activity, which subsequently decreased STAT3 function and halted M-MDSC differentiation (59). Our results unravel autophagy as a new pathway whose regulation could be exploited to drive MDSC differentiation and impair its suppressive activity.
Collectively, autophagy has been shown to promote or suppress tumorigenic events in a highly context-dependent manner (10, 60) ] leucine (Perkin Elmer) was added to the culture media 24 hours later. The next day, the medium was replaced with starvationinducing medium and an excess of unlabeled leucine. After 6 hours, cells were treated with lysosomal inhibitors (20 mM NH 4 Cl and 20 μm leupeptin or 100 nM bafilomycin) (Sigma-Aldrich) or left untreated for 16 hours. For precipitation of the degraded proteins, aliquots of culture supernatants were treated with 20% trichloroacetic acid and BSA (20 mg/ml). For isolation of nondegraded proteins (proteins in media and cell lysates), cells were lysed with a mild lysis buffer containing 0.1 N NaOH and 0.1 % wt/vol sodium deoxycholate. Counts per minute (cpm) were obtained using a beta counter. The protein degradation was calculated as degraded proteins / (nondegraded proteins + lysed cells).
RNA sequencing analysis. M-MDSCs were isolated from the spleens of B16-F10 melanoma cell-inoculated Atg5
ΔLysM and Atg5 fl/fl mice using magnetic beads. RNA was extracted with the Macherey-Nagel Nucleo-spin RNA kit. RNA sequencing was employed and singleend 75-bp-length reads were generated. Data were aligned to the mouse genome (mm9 version) with the TopHat2 algorithm. HT-seq
Immunofluorescence. Cells were seeded in coverslips pretreated with poly-L-lysine (Sigma-Aldrich) and fixed with 4% paraformaldehyde (Sigma-Aldrich) for 15 minutes in room temperature followed by 10 minutes of fixation with ice-cold methanol. Cells were permeabilized by using 0.1% saponin (Sigma-Aldrich), 2% BSA, and stained with mouse anti-LC3 antibody (1:20; catalog 0231/clone 5F10; nanoTools), rat anti-LAMP-1 (1:400; sc-19992/1D4B; Santa Cruz Biotechnology), rabbit anti-p62 (1:500; PM045/SQSTM1; MBL), rabbit anti-phospho-ULK1 (Ser556; 1:70; 5869S/D1H4; Cell Signaling Technology), mouse anti-LAMP-1 (1:400; sc-17768/E-5; Santa Cruz Biotechnology), rat anti-IA/IE (1:50; 14-5321-81/M5, 114.15.2; Biolegend), mouse antiRab7 (1:2000; ab50533/Rab7-117; Abcam), and goat anti-cathepsin D (1:100; sc-6486/C-20; Santa Cruz), then followed by incubation with Alexa Fluor 555 anti-mouse IgG (1:500; A28180; Invitrogen), Alexa Fluor 647 anti-rabbit IgG (1:200; A21245; Invitrogen), and Alexa Fluor 488 anti-rat IgG (1:250; A11006; Invitrogen). For visualization of the nuclei, DAPI (Sigma-Aldrich) was used. Samples were coverslipped with mowiol and visualized using a ×63 oil lens in a Leica SP5 inverted confocal live cell imaging system.
The numbers of LC3 puncta/cell, p62 puncta/cell, Rab7 puncta/ cell, LAMP-1 puncta/cell, and cathepsin D puncta/cell were calculated using a macro developed in Fiji software as described (64) . Colocalization of IA b with LAMP-1 and LC3 with p62 was calculated using crosscorrelation analysis with Volocity software (65) . For immunofluorescence staining of frozen tissues, tumors were embedded in OCT Tissue-Tek specimen matrix and cut in 7-μm-thick sections using Cryostar NX50 cryotome (Thermo Fisher Scientific) at -20°C. The sections were fixed in cold acetone for 10 minutes and left for at least 30 minutes at room temperature. Sections were blocked with 5% goat serum in TNT buffer (20 mM Tris, pH 7.6, 0.9% NaCl, 0.05% Tween) for 30 minutes at room temperature and stained with rat anti-mouse CD206 (1:200; MR5D3; Santa Cruz) and rat antimouse CD4 (1:200; 14-0041-82/GK1.5; eBioscience) either at 37°C for 1 hour in a humidified chamber or at 4°C overnight, followed by staining with goat anti-rat IgG Alexa Fluor 555 (1:500; A-21434; Cell Signaling) for 30 minutes at room temperature. For visualization of the nuclei, DAPI (1 mg/ml, 1:5,000 in PBS) was used. Slides were mounted with fluorescent mounting medium (Dako) and visualized using a digital slide scanner (Zeiss Axio Scan).
All measurements were done only in the tumor area, not considering any positive signal in stroma-surrounding areas. Quantitative PCR analysis. Cells were lysed in Buffer RLT (Qiagen) and RNA was extracted using a Qiagen RNeasy mini kit according to the manufacturer's instructions. First-strand cDNA synthesis was performed using Superscript II reverse transcriptase (Invitrogen). qPCR was carried out using the iTaq Universal SYBR Green Supermix (BioRad). Relative expression of target genes was calculated by comparing them to the expression of the housekeeping gene Hprt. The following primers were used: mouse Atg5 forward, 5′-AGCTCTGGATGGGACTG-3′; Atg5 reverse 5′-CTCCGTCGTG-GTCTGAT-3′; mouse Hprt forward, 5′-GTGAAACTGGAAAAGC-CAAA-3′; Hprt reverse, 5′-GGACGCAGCAACTGACAT-3′; mouse Ciita forward, 5′-TGCGTGTGATGGATGTCCAG-3′; Ciita reverse, 5′-CCAAAGGGGATAGTGGGTGTC-3′; mouse IA b (Qiagen); mouse jci.org Volume 128 Number 9 September 2018
Study approval. Patients with melanoma (stage IV) and healthy individuals were recruited through the Oncology Department, University Hospital "Laiko" (Athens, Greece). The Clinical Research Ethics Board of National and Kapodistrian University of Athens, Medical School, University Hospital "Laiko" (Athens, Greece) approved this study. Informed consent was obtained from all patients and healthy individuals prior to sample collection. All procedures in mice were in accordance with institutional guidelines and were reviewed and approved by the Greek Federal Veterinary Office (Athens, Greece, protocol 1474).
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and DESeq algorithm were used in order to measure gene expression and identify differential expression between the 2 groups of patients. Genes with a P value ≤ 0.05 and fold change ≥ 1.5 or ≤ -1.5 were considered to be up-and downregulated, respectively. Gene ontology analysis, pathway annotation, transcription factor enrichment, and comparison with various immunological and oncogenic gene signatures were performed with the use of DAVID knowledge base, Ingenuity Pathway Analysis software, and Molecular Signature Database (MSigDB) from Broad Institute (SRA accession number PRJNA395259).
Silencing of March1 by siRNA. Splenocytes from tumor-bearing C57BL/6 mice were incubated with biotin anti-mouse Ly6C (1:200; HK1.4; Biolegend) followed by streptavidin microbeads (Miltenyi Biotec), and then Ly6C Human subjects and isolation of MDSCs from peripheral blood. Peripheral blood from patients with melanoma (stage IV) and healthy individuals was collected in EDTA-coated tubes prior to systemic treatment. PBMCs were isolated using Histopaque 1077 (Sigma-Aldrich) (400 g, 30 minutes, room temperature), and washed and stained with antibodies against human CD14 (325604/HCD14), CD33 (303404/ WM53), CD15 (323018/W6D3), and HLA-DR (307616/L243) (Biolegend) prior to MDSC sorting. Sorted MDSCs were processed for autophagy pathway analysis with confocal microscopy.
Statistics. Statistical analyses were performed using an unpaired 2-tailed Student's t test. Two-way ANOVA statistical tests were applied in experiments with multiple comparisons. Data are mean ± SEM. Differences were considered statistically significant at P < 0.05. All data were analyzed using GraphPad Prism v5 software.
